Nisa Investment Advisors’s Cymabay Therapeutics CBAY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-1,211
| Closed | -$28.6K | – | 2828 |
|
|
2023
Q4 | $28.6K | Sell |
1,211
-880
| -42% | -$20.8K | ﹤0.01% | 1768 |
|
|
2023
Q3 | $31.2K | Buy |
2,091
+880
| +73% | +$13.1K | ﹤0.01% | 1873 |
|
|
2023
Q2 | $13.3K | Buy |
1,211
+61
| +5% | +$668 | ﹤0.01% | 2203 |
|
|
2023
Q1 | $10K | Hold |
1,150
| – | – | ﹤0.01% | 2164 |
|
|
2022
Q4 | $7K | Hold |
1,150
| – | – | ﹤0.01% | 2266 |
|
|
2022
Q3 | $4K | Hold |
1,150
| – | – | ﹤0.01% | 2329 |
|
|
2022
Q2 | $3K | Sell |
1,150
-4,320
| -79% | -$11.3K | ﹤0.01% | 2334 |
|
|
2022
Q1 | $17K | Sell |
5,470
-5,000
| -48% | -$15.5K | ﹤0.01% | 2099 |
|
|
2021
Q4 | $31K | Buy |
10,470
+9,320
| +810% | +$27.6K | ﹤0.01% | 1848 |
|
|
2021
Q3 | $4 | Hold |
1,150
| – | – | ﹤0.01% | 2276 |
|
|
2021
Q2 | $5 | Hold |
1,150
| – | – | ﹤0.01% | 2279 |
|
|
2021
Q1 | $5 | Sell |
1,150
-1,500
| -57% | -$7 | ﹤0.01% | 2259 |
|
|
2020
Q4 | $15K | Buy |
2,650
+1,250
| +89% | +$7.08K | ﹤0.01% | 2168 |
|
|
2020
Q3 | $10K | Hold |
1,400
| – | – | ﹤0.01% | 2126 |
|
|
2020
Q2 | $5K | Buy |
+1,400
| New | +$5K | ﹤0.01% | 2012 |
|
|
2020
Q1 | – | Sell |
-1,880
| Closed | -$4K | – | 2150 |
|
|
2019
Q4 | $4K | Buy |
1,880
+950
| +102% | +$2.02K | ﹤0.01% | 1958 |
|
|
2019
Q3 | $5K | Buy |
930
+500
| +116% | +$2.69K | ﹤0.01% | 1913 |
|
|
2019
Q2 | $3K | Hold |
430
| – | – | ﹤0.01% | 1957 |
|
|
2019
Q1 | $6K | Hold |
430
| – | – | ﹤0.01% | 1885 |
|
|
2018
Q4 | $3K | Hold |
430
| – | – | ﹤0.01% | 1890 |
|
|
2018
Q3 | $5K | Buy |
+430
| New | +$5K | ﹤0.01% | 1880 |
|